Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 24336791)

1.

Pharmacokinetics of intravenous immunoglobulin in multifocal motor neuropathy.

Vlam L, Cats EA, Willemse E, Franssen H, Medic J, Piepers S, Veldink JH, van den Berg LH, van der Pol WL.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1145-8. doi: 10.1136/jnnp-2013-306227. Epub 2013 Dec 11.

PMID:
24336791
2.

Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.

Kuitwaard K, de Gelder J, Tio-Gillen AP, Hop WC, van Gelder T, van Toorenenbergen AW, van Doorn PA, Jacobs BC.

Ann Neurol. 2009 Nov;66(5):597-603. doi: 10.1002/ana.21737.

PMID:
19938102
3.

Multifocal motor neuropathy: lost in conduction block?

Lin CS.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1062. doi: 10.1136/jnnp-2013-307200. Epub 2014 Jan 31. No abstract available.

PMID:
24487379
4.

Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial.

Piepers S, Van den Berg-Vos R, Van der Pol WL, Franssen H, Wokke J, Van den Berg L.

Brain. 2007 Aug;130(Pt 8):2004-10. Epub 2007 Jul 10.

5.

Association of FcRn expression with lung abnormalities and IVIG catabolism in patients with common variable immunodeficiency.

Freiberger T, Grodecká L, Ravcuková B, Kurecová B, Postránecká V, Vlcek J, Jarkovský J, Thon V, Litzman J.

Clin Immunol. 2010 Sep;136(3):419-25. doi: 10.1016/j.clim.2010.05.006.

PMID:
20627700
6.

Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy.

Cats EA, van der Pol WL, Piepers S, Franssen H, Jacobs BC, van den Berg-Vos RM, Kuks JB, van Doorn PA, van Engelen BG, Verschuuren JJ, Wokke JH, Veldink JH, van den Berg LH.

Neurology. 2010 Aug 31;75(9):818-25. doi: 10.1212/WNL.0b013e3181f0738e.

PMID:
20805527
7.
8.

Serum IgG levels as biomarkers for optimizing IVIg therapy in CIDP.

van Doorn PA, Kuitwaard K, Jacobs BC.

J Peripher Nerv Syst. 2011 Jun;16 Suppl 1:38-40. doi: 10.1111/j.1529-8027.2011.00304.x.

PMID:
21696496
9.

[Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment].

Léger JM, Viala K, Maisonobe T, Bouche P.

Bull Acad Natl Med. 2007 Oct;191(7):1395-407; discussion 1407-9. French.

PMID:
18447061
10.

A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study.

Misbah SA, Baumann A, Fazio R, Dacci P, Schmidt DS, Burton J, Sturzenegger M.

J Peripher Nerv Syst. 2011 Jun;16(2):92-7. doi: 10.1111/j.1529-8027.2011.00330.x.

PMID:
21692906
11.

IVIg dose increase in multifocal motor neuropathy: a prospective six month follow-up.

Baumann A, Hess CW, Sturzenegger M.

J Neurol. 2009 Apr;256(4):608-14. doi: 10.1007/s00415-009-0130-0. Epub 2009 Apr 9.

PMID:
19367358
12.

Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor.

Gouilleux-Gruart V, Chapel H, Chevret S, Lucas M, Malphettes M, Fieschi C, Patel S, Boutboul D, Marson MN, Gérard L, Lee M, Watier H, Oksenhendler E; DEFI study group.

Clin Exp Immunol. 2013 Feb;171(2):186-94. doi: 10.1111/cei.12002.

13.

Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients.

Léger JM, Viala K, Cancalon F, Maisonobe T, Gruwez B, Waegemans T, Bouche P.

J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):93-6.

PMID:
18079302
14.

Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.

Léger JM, Chassande B, Musset L, Meininger V, Bouche P, Baumann N.

Brain. 2001 Jan;124(Pt 1):145-53.

15.

Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block.

Nobile-Orazio E, Cappellari A, Meucci N, Carpo M, Terenghi F, Bersano A, Priori A, Barbieri S, Scarlato G.

J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):761-6.

16.

IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.

Fokkink WJ, Selman MH, Dortland JR, Durmuş B, Kuitwaard K, Huizinga R, van Rijs W, Tio-Gillen AP, van Doorn PA, Deelder AM, Wuhrer M, Jacobs BC.

J Proteome Res. 2014 Mar 7;13(3):1722-30. doi: 10.1021/pr401213z. Epub 2014 Feb 17.

PMID:
24533874
17.

Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial.

Harbo T, Andersen H, Hess A, Hansen K, Sindrup SH, Jakobsen J.

Eur J Neurol. 2009 May;16(5):631-8. doi: 10.1111/j.1468-1331.2009.02568.x. Epub 2009 Feb 19.

PMID:
19236457
18.

Subcutaneous immunoglobulin therapy for multifocal motor neuropathy.

Eftimov F, Vermeulen M, de Haan RJ, van den Berg LH, van Schaik IN.

J Peripher Nerv Syst. 2009 Jun;14(2):93-100. doi: 10.1111/j.1529-8027.2009.00218.x.

PMID:
19691531
19.

Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathy.

Kuitwaard K, van Doorn PA, Vermeulen M, van den Berg LH, Brusse E, van der Kooi AJ, van der Pol WL, van Schaik IN, Notermans N, Tio-Gillen AP, van Rijs W, van Gelder T, Jacobs BC.

J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):859-61. doi: 10.1136/jnnp-2012-304670. Epub 2013 Mar 28.

PMID:
23538070
20.

Long-term therapy with high doses of subcutaneous immunoglobulin in multifocal motor neuropathy.

Harbo T, Andersen H, Jakobsen J.

Neurology. 2010 Oct 12;75(15):1377-80. doi: 10.1212/WNL.0b013e3181f735ce.

PMID:
20938030
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk